5-(N-Methyl-2-aminopropyl)-23-dihydro-1H-indene (5-MAPDI) also known as indanylmethylaminopropane (IMP) is a putative entactogen and selective serotonin releasing agent (SSRA) of the amphetamine family. 5-MAPDI has not been studied in humans but based […]
List of articles in "Drug" category - Page 130
4-Ethylamphetamine
4-Ethylamphetamine (4-EA) is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes. It likely produces stimulant effects via inducing the release of serotonin norepinephrine and/or dopamine […]
Oxilofrine
Oxilofrine (also known as methylsynephrine hydroxyephrine oxyephrine and 4-HMP) is a stimulant drug and is an amphetamine chemically related to ephedrine and to synephrine.Oxilofrine is currently a WADA prohibited substance […]
Phenylisobutylamine
Phenylisobutylamine also known as α-ethylphenethylamine Butanphenamine B or AEPEA is a stimulant drug of the phenethylamine class. It is a higher homologue of amphetamine differing from amphetamine’s molecular structure only […]
6-CAT
6-Chloro-2-aminotetralin (6-CAT) is a drug which acts as a selective serotonin releasing agent (SSRA) and is a putative entactogen in humans. It is a rigid analogue of para-chloroamphetamine (PCA).According to […]
MDAT
67-Methylenedioxy-2-aminotetralin (MDAT) is a drug developed in the 1990s by a team at Purdue University led by David E. Nichols. It appears to act as a serotonin releasing agent based […]
2-Amino-12-dihydronaphthalene
2-Amino-12-dihydronapthalene (2-ADN) also known as 2-aminodilin (2-AD) is a stimulant drug. It is a rigid analogue of phenylisobutylamine and substitutes amphetamine for it in rat discrimination tests although at approximately […]
Pyriprole
Pyriprole (trade name Prac-tic) is for veterinary use on dogs against external parasites such as fleas and ticks.Pyriprole is a phenylpyrazole derivative similar to fipronil. Although recently introduced (in the […]
Rontalizumab
Rontalizumab is a humanized monoclonal antibody being developed by Genentech. As of November 2009 it is being investigated in a clinical trial or the treatment of systemic lupus erythematosus.
Abnormal cannabidiol
Abnormal cannabidiol (abn-cbd) is a synthetic regioisomer of cannabidiol which unlike most other cannabinoids produces vasodilator effects lowers blood pressure and induces cell migration cell proliferation and mitogen-activated protein kinase […]